Alector Q2 FY26 net loss narrows to $23 million; revenue drops to $3.3 million

Reuters2026/08/06 20:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Alector posted a Q2 net loss of USD 23 million, narrowing from USD 30.5 million a year earlier; loss per share improved to USD 0.21.
Collaboration revenue fell 57.83% to USD 3.32 million, due to lower revenue recognized for the AL101 AD program.
R&D expenses dropped 29.51% to USD 19.46 million; G&A expenses slid 42.69% to USD 8.25 million, both on lower personnel costs.
Cash, cash equivalents and investments totaled USD 172.8 million at June 30; runway expected at least through 2027.
Selected AL137 as lead ABC-enabled anti-amyloid beta antibody for Alzheimer’s, targeting an IND submission in Q1 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alector Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061605PRIMZONEFULLFEED9804845) on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Alector Q2 FY26 net loss narrows to $23 million; revenue drops to $3.3 million

You may also like

Crypto prices